Skip Navigation


Rheumatology Advance Access originally published online on June 29, 2004
Rheumatology 2004 43(9):1186-1189; doi:10.1093/rheumatology/keh284
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
43/9/1186    most recent
keh284v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Marks, S. D.
Right arrow Articles by Dillon, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marks, S. D.
Right arrow Articles by Dillon, M. J.
Related Collections
Right arrow Diagnostics and Imaging Procedures
Right arrow Systemic Lupus Erythematosus and Autoimmunity
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology Vol. 43 No. 9 © British Society for Rheumatology 2004; all rights reserved

Paper

The use of the British Isles Lupus Assessment Group (BILAG) index as a valid tool in assessing disease activity in childhood-onset systemic lupus erythematosus

S. D. Marks, C. Pilkington1, P. Woo1 and M. J. Dillon

Nephro-Urology Unit, Institute of Child Health and 1 Department of Paediatric Rheumatology, Great Ormond Street Hospital for Children NHS Trust, London, UK.

Correspondence to: S. D. Marks, Nephro-Urology Unit, Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK. E-mail: s.marks{at}ich.ucl.ac.uk

Objectives. The British Isles Lupus Assessment Group (BILAG) index is a standardized systemic lupus erythematosus (SLE) disease activity assessment. The main aim of this study was to correlate the BILAG index with laboratory measures of disease activity in childhood-onset SLE with and without biopsy-proven lupus nephritis.

Method. Prospective observational comparison study of the BILAG index in 21 SLE patients under 18 yr of age over a 12-month period in a tertiary referral paediatric outpatient clinic.

Results. Eleven patients with lupus non-nephritis and 10 patients with lupus nephritis were reviewed. The lupus nephritis patients had significantly (P<0.001) more admissions over a similar time interval since diagnosis. The renal BILAG disease activity scores were significantly greater (P = 0.013) in the lupus nephritis group (range 1–9, median 3.0, compared with 0–3 and 1.0 in the lupus non-nephritis group). The total BILAG scores and patient visual analogue scores (VAS) were higher in the lupus nephritis groups, unlike the lower physician VAS, but these differences were not statistically significant compared with other laboratory indices of disease activity.

Conclusions. The BILAG index is a useful tool in monitoring disease activity in children and adolescents with SLE. The data collected for the BILAG index can be used serially and effectively by different clinicians over time to enable recording of disease status at sequential assessments. The lower patient VAS in the lupus non-nephritis group was not significant and may reflect the patients’ own perception of lethargy at times of increased disease activity.

KEY WORDS: Systemic lupus erythematosus, Childhood, Lupus nephritis, Disease activity score, BILAG index


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 PsychosomaticsHome page
L. Wittmann, T. Sensky, L. Meder, B. Michel, T. Stoll, and S. Buchi
Suffering and Posttraumatic Growth in Women With Systemic Lupus Erythematosus (SLE): A Qualitative/Quantitative Case Study
Psychosomatics, July 1, 2009; 50(4): 362 - 374.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
A Podolskaya, M Stadermann, C Pilkington, S D Marks, and K Tullus
B cell depletion therapy for 19 patients with refractory systemic lupus erythematosus
Arch. Dis. Child., May 1, 2008; 93(5): 401 - 406.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
I. Kone-Paut, M. Piram, S. Guillaume, and T.A. Tran
Review: Lupus in adolescence
Lupus, August 1, 2007; 16(8): 606 - 612.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.